Eli Lilly Ceo To Retire

Eli Lilly CEO John Lechleiter will retire at the end of the year, the company said Wednesday, capping nearly four decades at the pharmaceutical manufacturer and an eight-year tenure at its helm.

BING NEWS:
  • Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO
    Bengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their highly successful obesity treatment medications ...
    05/10/2024 - 7:00 pm | View Link
  • Cipla Wants to Partner with Eli Lilly (NYSE:LLY) in India
    Indian pharmaceutical firm Cipla is open to a potential partnership with U.S. drugmaker Eli Lilly (NYSE:LLY) to bring its obesity treatment drugs ...
    05/10/2024 - 10:01 am | View Link
  • Lilly could partner with Cipla to market GLP-1 drugs in India
    Cipla is open to partnering with Eli Lilly to market Mounjaro for diabetes and Zepbound for weight loss in India.
    05/10/2024 - 6:01 am | View Link
  • Open to market Eli Lilly’s weight loss drugs in India: Cipla CEO
    Indian pharma major Cipla said that it is open to the possibility of marketing Eli Lilly’s weight loss drugs in India. “We currently have a very nice working relation with Eli Lilly for the insulin ...
    05/9/2024 - 11:14 pm | View Link
  • India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
    Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday.
    05/9/2024 - 10:52 pm | View Link
  • More
BING SEARCH:
  • Lilly CEO reaffirms commitment to Chinese market amid US threat against ...
    At a time of heightened geopolitical tensions between the U.S. and China, Eli Lilly’s CEO said the Indianapolis-based company remains committed to the Chinese market.
    05/4/2024 - 12:24 am | View Website
  • Eli Lilly CEO and Key Executive Team | Craft.co
    Eli Lilly's Chairman and Chief Executive Officer is David A. Ricks. Other executives include Daniel M. Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories; Anat Ashkenazi, Senior Vice President and Chief Financial Officer and 23 others. See the full leadership team at Craft.
    05/3/2024 - 2:52 pm | View Website
  • Eli Lilly and Company
    In 1991, Vaughn Bryson was named CEO of Eli Lilly and Company. During his 20-month tenure, the company reported its first quarterly loss as a publicly traded company.
    05/3/2024 - 8:04 am | View Website
  • DAVE RICKS Chair and CEO, Eli Lilly and Company
    © 2024 Eli Lilly and Company 1 DAVE RICKS. Chair and CEO, Eli Lilly and Company. J. P. Morgan Healthcare Conference. January 9, 2024
    05/3/2024 - 4:07 am | View Website
  • David A. Ricks | Eli Lilly and Company
    David A. Ricks. Dave Ricks is chair and chief executive officer of Eli Lilly and Company. A Lilly veteran for more than 25 years, with experience in marketing, sales, drug development and international operations, Dave became CEO in January 2017 and was elected chair of the company’s board of directors effective June 2017.
    05/3/2024 - 12:04 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News